Concepedia

Amal Mishriki

AM

Statistics

Publications

4

Citations

90

H-Index

4

Active since

1987

Affiliations

Cairo University(Current)

Taibah University

Amal Mishriki is an author at Cairo University specializing in atherosclerosis, metabolic syndrome, and vascular biology.

Top concepts

Publications per year

1987–2021

4

Publications

4

Protective effect of tolvaptan against cyclophosphamide‐induced nephrotoxicity in rat models

Mohamed Elshabrawy, Amal Mishriki, Hisham Attia et al. · Pharmacology Research & Perspectives · 2020 · 36 citations · Full text

Do MDR1 and SLCO1B1 Polymorphisms Influence the Therapeutic Response to Atorvastatin? A Study on a Cohort of Egyptian Patients with Hypercholesterolemia

Mona F. Shabana, Amal Mishriki, Marianne Samir Makboul Issac et al. · Molecular Diagnosis & Therapy · 2013 · 28 citations

, , +14

Nebivolol protects against cyclophosphamide‐induced nephrotoxicity through modulation of oxidative stress, inflammation, and apoptosis

Hanaa Wanas, Mohamed Elshabrawy, Amal Mishriki et al. · Clinical and Experimental Pharmacology and Physiology · 2021 · 16 citations

Comparative Pharmacodynamics and Pharmacokinetics of Conventional and Long‐Acting Propranolol

Dyal C. Garg, Nader S. Jallad, Amal Mishriki et al. · The Journal of Clinical Pharmacology · 1987 · 10 citations

1–4 of 4